Rachael van

Rachael Van is an Associate Scientist in Cell Biology Research at United Therapeutics Corporation, with a progressive career that began in 2019. Prior roles at United Therapeutics include Research Associate III, Research Associate II, and Bioprocess Associate II, focusing on cell biology. Prior to this, Rachael served as a Research Analyst at Duke University from 2015 to 2019, leading projects on human dendritic cells under GMP conditions for clinical trials, and participated in the Duke Brain Tumor Immunotherapy Program. Rachael's early experience includes positions as a Research Technician II at The Duke Human Vaccine Institute, a Research Technician at North Carolina State University's College of Veterinary Medicine, and various roles at Louisiana State University, encompassing research in microbiology and bacteriology. Rachael holds a Master of Science in Comparative Biomedical Sciences from North Carolina State University and a Bachelor of Science in Microbiology from Louisiana State University.